retatrutide dose escalation trial for the treatment of obesity, obstructive sleep apnea and knee osteoarthritis: Rationale and design of the TRIUMPH registrational clinical trials Triple hormone receptor agonist retatrutide

Glucagon-like peptide-1 receptor agonists (GLP-1s) are commonly prescribed to manage type 2 diabetes and obesity

Unfamiliarity with withdrawing medication from a vial into a syringe and coupled with confusion between different units of measurement (e.g., milliliters, milligrams, and units) may have contributed to dosing errors, the FDA said

Losing too much lean mass can cause bone loss and osteoporosis

This phenomenon affords mutual benefit by promoting longevity and tissue integrity for helminth and host, respectively

If the vitamin is administered by injection in response to a deficiency and enters the bloodstream directly in high concentrations, an immunologic reaction with skin reactions is possible